Analysis of the clinical characteristic and drug resistance of gram -negative bacillus in Department of Respir-atory Medicine
10.3760/cma.j.issn.1008-6706.2016.12.023
- VernacularTitle:呼吸内科住院患者革兰阴性杆菌感染100例临床分析
- Author:
Lehua HUANG
;
Hailong CHEN
;
Weijuan LIANG
- Publication Type:Journal Article
- Keywords:
Respiratory therapy department,hospital;
Gram -negative bacilli;
Drug resistance,microbial
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(12):1844-1846,1847
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics and drug resistance of gram -negative bacillus in Department of Respiratory Medicine.Methods 100 patients in Department of Respiratory Medicine were selected, analyzed the clinical characteristic and drug resistance of 125 strains of gram -negative bacillus that was separated. Results 125 strains of pathogenic gram negative bacilli were isolated out of 100 patients,among which 34 strains were pneumonia klebsiella bacteria,24 strains were acinetobacter baumannii,18 strains were pseudomonas aeruginosa, 10 strains were enterobacter cloacae,18 strains were escherichia coli and 21 strains were other bacteria.Results The drug resistance rates were 79.4%,76.5%,76.5% and 76.5% respectively in klebsiella pneumoniae to amikacin, cefotaxime,ampicillin and imipenem,was more sensitive to meropenem and cefoperazone,the drug resistance rate was 100.0% in acinetobacter baumannii to ampicillin and cefazolin,and was 91.7% to ceftriaxone,and the resistance rate for other drugs are higher generally.The drug resistance rate was 100.0% in pseudomonas aeruginosa to ampicillin and ceftriaxone,and was 94.4% to cefotaxime and levofloxacin,the drug resistance rate was 90.0% in enterobacter cloacae to ampicillin,and was 60.0% to ceftriaxone,cefazolin and cefoxitin,the drug resistance rate on the other drug was relatively low.Conclusion Klebsiella pneumoniae,acinetobacter baumanni and pseudomonas aeruginosa were the main gram negative bacillis the cause hospitalized patients with drug resistance.
